Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Reykjavik Political Voice.
Holding(s) in Company
GlobeNewswire, Inc.
·
March 5, 2025
NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq Minerals Ltd. 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if...
Stellantis Reports Q1 2025 Net Revenues and Shipments
GlobeNewswire, Inc.
·
April 30, 2025
Stellantis Reports Q1 2025 Net Revenues and Shipments Net revenues of €35.8 billion, down 14% compared to Q1 2024 primarily due to lower shipment volumes, as well as unfavorable mix and pricing Consolidated shipments(1) of 1,217 thousand units,...
US Antimicrobial Plastics Market Set to Expand at a 8.20% CAGR, Reaching USD 14.634 Billion by 2032
EIN Presswire
·
April 29, 2025
The US Antimicrobial Plastics market segmentation, based on additive includes Inorganic (Silver, Zinc, Copper) and Organic (ОВРА, Triclosan). NEW YORK, NJ, UNITED STATES, April 29, 2025 /EINPresswire.com/ -- The US Antimicrobial Plastics Market...
Plan3 Launches the Airline ImPax Report, New Monthly Research Helping Airlines Improve Passenger Disruption Management
EIN Presswire
·
December 5, 2024
Leveraging Disruption Data to Transform Airline Recovery Strategies and Enhance Customer Experience REYKJAVIK, ICELAND, December 5, 2024 /EINPresswire.com/ -- Each year, hundreds of millions of passengers are impacted by delays and...
Holding(s) in Company
GlobeNewswire, Inc.
·
November 5, 2024
Reykjavík, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
GlobeNewswire, Inc.
·
November 4, 2024
REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK...
Open Positions at the Slovenian Embassy in Copenhagen
Government of Slovenia
·
March 6, 2025
SLOVENIA, March 6 - Both roles are based at the Embassy in Copenhagen but will involve engagement across Denmark, Sweden, Finland, Norway, and Iceland. These positions play a vital role in promoting Slovenian culture, diplomacy, and engagement in...
Holding(s) in Company
GlobeNewswire, Inc.
·
October 31, 2024
Reykjavík, Oct. 31, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...
Oculis to Present at Upcoming March Investor Conference
GlobeNewswire, Inc.
·
March 5, 2025
ZUG, Switzerland, March 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis will be attending...
Tourism in Greenland – Expanding the Runway towards Independence
The Arctic Institute
·
February 18, 2025
Back to Publications Dash-8 airplanes lined up on the runway in Nuuk, Greenland. Photo: Gunnar Thór Jóhannesson October 28, 2024, saw the official opening of Nuuk’s new international airport. Through the extension of the existing runway, the...
Golden State Film Festival 2025 Supports Independent Film Productions in Hollywood
EIN Presswire
·
March 4, 2025
HOLLYWOOD, CA, UNITED STATES, March 4, 2025 /EINPresswire.com/ -- Golden State Film Festival 2025 took place at the TCL Chinese 6 Theatres in Hollywood this past February. Both local and international filmmakers attended the seven-day event to...
Successful Completion of 2024 Exploration Field Season
GlobeNewswire, Inc.
·
October 24, 2024
Reykjavík, Oct. 24, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Successful Completion of 2024 Exploration Field Season **Completion of full 2024 >8,600m exploration programme ahead of schedule** ***First drilling...
Block Listing Six Monthly Return
GlobeNewswire, Inc.
·
October 24, 2024
Reykjavík, Oct. 24, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company”) Block Listing Six Monthly Return TORONTO, ONTARIO – October 24, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ First North: AMRQ), an independent mine development company...
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GlobeNewswire, Inc.
·
April 28, 2025
VYVGART® is first-and-only targeted IgG Fc-antibody fragment for CIDP First novel mechanism of action for CIDP treatment in more than 30 years CHMP positive opinion based on ADHERE data, the largest ever CIDP clinical trial European Commission...
Greenland During Trump 2.0: Is America Poised for an Historic Arctic Territorial Expansion?
The Arctic Institute
·
January 21, 2025
Back to Publications The aircraft that carried then U.S Secretary of State John Kerry to Greenland in 2016, sitting on the runway at Kangerlussuaq International Airport in Kangerlussuaq, Greenland. Photo: U.S. Department of State It was just over...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
GlobeNewswire, Inc.
·
February 21, 2025
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is...
Holding(s) in Company
GlobeNewswire, Inc.
·
October 14, 2024
Reykjavik, Oct. 14, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...
European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
GlobeNewswire, Inc.
·
October 10, 2024
REYKJAVIK, Iceland, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines...
Amendments and Conversion of Convertible Notes
GlobeNewswire, Inc.
·
October 4, 2024
Reykjavik, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Amendments and Conversion of Convertible Notes TORONTO, ONTARIO – 4 October 2024 - Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent...
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
GlobeNewswire, Inc.
·
April 28, 2025
VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a healthcare professional PITTSBURGH, April 28,...